14
Views
44
CrossRef citations to date
0
Altmetric
Original Article

Primary Osteogenic Sarcoma of the Femur: A Model for the Use of Preoperative Chemotherapy in High Risk Malignant Tumors

, , , , , , & show all
Pages 181-192 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

William S. Ferguson & Allen M. Goorin. (2001) Current Treatment of Osteosarcoma. Cancer Investigation 19:3, pages 292-315.
Read now

Articles from other publishers (43)

Santiago A. Lozano‐Calderón, Jose Ignacio Albergo, Olivier Q. Groot, Nelson A. Merchan, Jad M. El Abiad, Vanessa Salinas, Luis Carlos Gomez Mier, Camilo Soto Montoya, Marco L. Ferrone, John E. Ready, Francisco J. Linares, Adam S. Levin, Manuel Peleteiro Pensado, José Juan Pozo Kreilinger, Irene Barrientos Ruiz, Eduardo J. Ortiz‐Cruz, Mark C. Gebhardt, Gregory M. Cote, Edwin Choy, Dimitrios Spentzos, Yin P. Hung, Vikram Deshpande, Ivan A. Chebib, Robert Allan McCulloch, Germán Farfalli, Luis Aponte Tinao, Carol D. Morris, Gunnlaugur Petur Nielsen, Megan E. Anderson & Lee M. Jeys. (2022) Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma. Cancer 129:1, pages 60-70.
Crossref
Douglas J. Harrison, Yueh‐Yun Chi, Jing Tian, Pooja Hingorani, Leo Mascarenhas, Geoffrey B. McCowage, Brenda J. Weigel, Rajkumar Venkatramani, Suzanne L. Wolden, Torunn I. Yock, David A. Rodeberg, Andrea A. Hayes‐Jordan, Lisa A. Teot, Sheri L. Spunt, William H. Meyer, Douglas S. Hawkins, Barry L. Shulkin & Marguerite T. Parisi. (2020) Metabolic response as assessed by 18 F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee . Cancer Medicine 10:3, pages 857-866.
Crossref
Zeinab Jamali, Mortaza Taheri‐Anganeh, Zahra Shabaninejad, Abdolkhalegh Keshavarzi, Hajar Taghizadeh, Zahra Sadat Razavi, Reza Mottaghi, Mohammadreza Abolhassan, Ahmad Movahedpour & Hamed Mirzaei. (2020) Autophagy regulation by microRNAs : Novel insights into osteosarcoma therapy . IUBMB Life 72:7, pages 1306-1321.
Crossref
A. Kevin Raymond. 2020. Oncological Surgical Pathology. Oncological Surgical Pathology 285 457 .
Ahmed Mohamed Rashad, Ahmed Mohamed Abougabal, Shady Hassan Fadel, Walid Mohamed Omar & Khaled Mohamed Moghazy. (2019) Value of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in assessment of response to preoperative chemotherapy in pediatric sarcoma. Egyptian Journal of Radiology and Nuclear Medicine 50:1.
Crossref
Xue-Song Sun, Li-Ting Liu, Sai-Lan Liu, Shan-Shan Guo, Yue-Feng Wen, Hao-Jun Xie, Qing-Nan Tang, Yu-Jing Liang, Xiao-Yun Li, Jin-Jie Yan, Jun Ma, Qiu-Yan Chen, Lin-Quan Tang & Hai-Qiang Mai. (2019) Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapy. BMC Cancer 19:1.
Crossref
Tadashi Kondo. 2017. Osteosarcoma - Biology, Behavior and Mechanisms. Osteosarcoma - Biology, Behavior and Mechanisms.
Sayantan Ray, Suman Saha, Biswanath Sa & Jui Chakraborty. (2017) In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma. Drug Delivery and Translational Research 7:2, pages 259-275.
Crossref
Renxiong Wei, Gang Cao, Zhouming Deng, Jiajia Su & Lin Cai. (2016) miR-140-5p attenuates chemotherapeutic drug-induced cell death by regulating autophagy through inositol 1,4,5-trisphosphate kinase 2 (IP3k2) in human osteosarcoma cells . Bioscience Reports 36:5.
Crossref
Daisuke Kubota, Nobuyoshi Kosaka, Tomohiro Fujiwara, Akihiko Yoshida, Yasuhito Arai, Zhiwei Qiao, Fumitaka Takeshita, Takahiro Ochiya, Akira Kawai & Tadashi Kondo. (2016) miR-125b and miR-100 Are Predictive Biomarkers of Response to Induction Chemotherapy in Osteosarcoma. Sarcoma 2016, pages 1-11.
Crossref
Francisco Forriol. 2016. Cañadell's Pediatric Bone Sarcomas. Cañadell's Pediatric Bone Sarcomas 1 26 .
Li-Ting Liu, Lin-Quan Tang, Qiu-Yan Chen, Lu Zhang, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Chong Zhao, Xiang Guo, Ka-Jia Cao, Chao-Nan Qian, Mu-Sheng Zeng, Jin-Xin Bei, Ming-Huang Hong, Jian-Yong Shao, Ying Sun, Jun Ma & Hai-Qiang Mai. (2015) The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics 93:4, pages 862-869.
Crossref
Pablo Berlanga, Adela Cañete, Roberto Díaz, Marta Salom, Francisco Baixauli, Jacinto Gómez, Margarita Llavador & Victoria Castel. (2015) Presentation and Long-term Outcome of High-grade Osteosarcoma. Journal of Pediatric Hematology/Oncology 37:5, pages e272-e277.
Crossref
Tadashi Kondo & Akira Kawai. (2014) A proteomics approach for the development of sarcoma biomarkers. EuPA Open Proteomics 4, pages 121-128.
Crossref
LU CHEN, KE JIANG, HUA JIANG & PENG WEI. (2014) miR-155 mediates drug resistance in osteosarcoma cells via inducing autophagy. Experimental and Therapeutic Medicine 8:2, pages 527-532.
Crossref
Shibing Guo, Rui Bai, Wanlin Liu, Aiqing Zhao, Zhenqun Zhao, Yuxin Wang, Yong Wang, Wei Zhao & Wenxuan Wang. (2014) miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy. Tumor Biology 35:7, pages 7025-7034.
Crossref
Xuefeng Li, Sijia Wang, Yan Chen, Guifeng Liu & Xiaoyu Yang. (2014) miR-22 targets the 3′ UTR of HMGB1 and inhibits the HMGB1-associated autophagy in osteosarcoma cells during chemotherapy. Tumor Biology 35:6, pages 6021-6028.
Crossref
Abby R. Rosenberg, James R. Anderson, Elizabeth Lyden, David A. Rodeberg, Suzanne L. Wolden, Simon C. Kao, David M. Parham, Carola Arndt & Douglas S. Hawkins. (2014) Early response as assessed by anatomic imaging does not predict failure-free survival among patients with Group III rhabdomyosarcoma: A report from the Children’s Oncology Group. European Journal of Cancer 50:4, pages 816-823.
Crossref
Daisuke Kubota, Kenta Mukaihara, Akihiko Yoshida, Hitoshi Tsuda, Akira Kawai & Tadashi Kondo. (2013) Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcoma. Journal of Proteomics 91, pages 393-404.
Crossref
S. SALAS, T.-K. HUYNH, R. GIORGI, J.-L. DEVILLE, G. BOLLINI, G. CURVALE, A. BLESIUS, J.-C. GENTET, B. BUI, C. BOUVIER & F. DUFFAUD. (2011) A study of 28 flat bone osteosarcomas: prognostic factors and early and long-term outcome. European Journal of Cancer Care 20:3, pages 322-329.
Crossref
Kazutaka Kikuta, Naobumi Tochigi, Shigeru Saito, Tadakazu Shimoda, Hideo Morioka, Yoshiaki Toyama, Ako Hosono, Yoshiyuki Suehara, Yasuo Beppu, Akira Kawai, Setsuo Hirohashi & Tadashi Kondo. (2010) Peroxiredoxin 2 as a chemotherapy responsiveness biomarker candidate in osteosarcoma revealed by proteomics. PROTEOMICS – Clinical Applications 4:5, pages 560-567.
Crossref
Andrea FerrariRosalba MiceliCristina MeazzaMichela CasanovaFrancesca FaviniCarlo MorosiGiovanna TrecateAlfonso MarchianòRoberto LukschGraziella CefaloMonica TerenzianiFilippo SpreaficoDaniela PolastriMarta PoddaSerena CataniaElisabetta SchiavelloPatrizia GiannatempoLorenza GandolaMaura MassiminoLuigi Mariani. (2010) Comparison of the Prognostic Value of Assessing Tumor Diameter Versus Tumor Volume at Diagnosis or in Response to Initial Chemotherapy in Rhabdomyosarcoma. Journal of Clinical Oncology 28:8, pages 1322-1328.
Crossref
David A. RodebergJulie A. StonerAndrea Hayes-JordanSimon C. KaoSuzanne L. WoldenSteve J. QualmanWilliam H. MeyerDouglas S. Hawkins. (2009) Prognostic Significance of Tumor Response at the End of Therapy in Group III Rhabdomyosarcoma: A Report From the Children's Oncology Group. Journal of Clinical Oncology 27:22, pages 3705-3711.
Crossref
Megan Burke, James R. Anderson, Simon C. Kao, David Rodeberg, Stephen J. Qualman, Suzanne L. Wolden, William H. Meyer & Philip P. Breitfeld. (2007) Assessment of Response to Induction Therapy and Its Influence on 5-Year Failure-Free Survival in Group III Rhabdomyosarcoma: The Intergroup Rhabdomyosarcoma Study-IV Experience—A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Journal of Clinical Oncology 25:31, pages 4909-4913.
Crossref
Andrea T. Deyrup, Anthony G. Montag, Carrie Y. Inwards, Zhiheng Xu, Ronald G. Swee & K. Krishnan Unni. (2007) Sarcomas Arising in Paget Disease of Bone: A Clinicopathologic Analysis of 70 Cases. Archives of Pathology & Laboratory Medicine 131:6, pages 942-946.
Crossref
Cindy L. Schwartz, Richard Gorlick, Lisa Teot, Mark Krailo, Zhengjia Chen, Allen Goorin, Holcombe E. Grier, Mark L. Bernstein & Paul Meyers. (2007) Multiple Drug Resistance in Osteogenic Sarcoma: INT0133 From the Children's Oncology Group. Journal of Clinical Oncology 25:15, pages 2057-2062.
Crossref
Robert Howman-Giles, Rodney J. Hicks, Geoffrey McCowage & David K. Chung. 2006. Pediatric PET Imaging. Pediatric PET Imaging 267 301 .
Douglas S. Hawkins, Joseph G. Rajendran, Ernest U. ConradIIIIII, James D. Bruckner & Janet F. Eary. (2002) Evaluation of chemotherapy response in pediatric bone sarcomas by [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomography. Cancer 94:12, pages 3277-3284.
Crossref
J.H Dalle, A Auvrignon, G Vassal, G Leverger & C Kalifa. (2001) Interaction méthotrexate–ciprofloxacine : à propos de deux cas d’intoxication sévère. Archives de Pédiatrie 8:10, pages 1078-1081.
Crossref
Klemens Trieb & Rainer Kotz. (2001) Proteins expressed in osteosarcoma and serum levels as prognostic factors. The International Journal of Biochemistry & Cell Biology 33:1, pages 11-17.
Crossref
Florence Duffaud, Laurence Digue, Marjorie Baciuchka-Palmaro, Fran�oise Volot, Catherine Perles-Daniel, Louise Garbe & Roger Favre. (2000) Osteosarcomas of flat bones in adolescents and adults. Cancer 88:2, pages 324-332.
Crossref
Klemens Trieb, Teresa Lechleitner, Susanna Lang, Reinhard Windhager, Rainer Kotz & Stephan Dirnhofer. (1998) Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy. Human Pathology 29:10, pages 1050-1055.
Crossref
Klemens Trieb, Theresia Lechleitner, Susanna Lang, Reinhard Windhager, Rainer Kotz & Stephan Dirnhofer. (1998) Evaluation of HLA-DR Expression and T-Lymphocyte Infiltration in Osteosarcoma. Pathology - Research and Practice 194:10, pages 679-684.
Crossref
G. Delépine, N. Delépine, J.-M. Ziza, J.-C. Desbois, J.-L. Misset & D. Lardé. 1998. CT and MRI in Oncology. CT and MRI in Oncology 367 380 .
Mark C. Gebhardt, Katsuyuki Kusuzaki, Henry J. Mankin & Dempsey S. Springfield. (2005) An assay to measure adriamycin binding in osteosarcoma cells. Journal of Orthopaedic Research 12:5, pages 621-627.
Crossref
Johannes Björnsson, Carrie Y. Inwards, Lester E. Wold, Franklin H. Sim & William F. Taylor. (1993) Prognostic significance of spontaneous tumour necrosis in osteosarcoma. Virchows Archiv A Pathological Anatomy and Histopathology 423:3, pages 195-199.
Crossref
S. J. Withrow, D. E. Thrall, R. C. Straw, B. E. Powers, R. H. Wrigley, S. M. Larue, R. L. Page, D. C. Richardson, K. W. Bissonette, C. W. Betts, D. J. Deyoung, S. L. Richter, V. J. Jameson, S. L. George, R. Dodge, E. L. Gillette & E. B. Douple. (1993) Intra-arterial cisplatin with or without radiation in limb-sparing for canine osteosarcoma. Cancer 71:8, pages 2484-2490.
Crossref
Dale B. Glasser, Joseph M. Lane, Andrew G. Huvos, Ralph C. Marcove & Gerald Rosen. (1992) Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience. Cancer 69:3, pages 698-708.
Crossref
A. W. Craft. 1992. Cancer in Children. Cancer in Children 282 294 .
N Delépine, G Delépine, JC Desbois, H Cornille & C Jasmin. (1990) Osteogenic osteosarcoma: a model of curable disease by multidiscipIinary approach of treatment. Biomedicine & Pharmacotherapy 44:5, pages 243-248.
Crossref
E. Boven & H. M. Pinedo. 1989. Surgical Oncology. Surgical Oncology 174 187 .
Cameron K Tebbi & John Gaeta. (1988) Osteosarcoma. Pediatric Annals 17:4, pages 285-300.
Crossref
A. W. Craft. 1986. Cancer in Children. Cancer in Children 290 299 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.